NCT02203136View on ClinicalTrials.gov

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

June 25, 2014

Primary Completion Date

May 16, 2019

Study Completion Date

May 16, 2019

Conditions
Bladder Cancer
Interventions
PROCEDURE

Tissue Biopsy

During bladder cancer surgery, tissue specimen taken for molecular profiling.

PROCEDURE

Magnetic Resonance Imaging (MRI)

3 Tesla pelvic magnetic resonance imaging (MRI) performed four weeks after bladder cancer surgery.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02203136 - Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging | Biotech Hunter | Biotech Hunter